Aside from the loss of MHC I expression on tumor cells during EMT, that makes them resistant to CD8+T and more susceptible to NK cells lysis, there are EMT-associated changes in the expression of ligands for NK cell receptors that make tumor cells more susceptible NK cell targets. The gene discussed is CD8A; the disease is neoplasm.